Disclaimer

Healthcare Professional Educational & Regulatory Disclosure

Innovations in Infant Nutrition Webinar Series

United States Legal Notice

1. Intended Audience & Use Restriction

This program is intended exclusively for licensed healthcare professionals in the United States. It is not directed to consumers and is not intended for public dissemination, marketing use, or patient-facing distribution.

The information presented is educational in nature and is not intended to serve as advertising, product labeling, or promotional claims.

2. No Medical Advice

This program does not provide medical advice, diagnostic guidance, or treatment recommendations. Nothing presented should be construed as a recommendation for a specific product, feeding method, or clinical protocol.

Healthcare professionals remain solely responsible for independent clinical judgment and patient counseling decisions.

3. Breastfeeding Acknowledgment

Breast milk is recognized by major U.S. health authorities as the recommended feeding standard when available and appropriate.

Any reference to human milk composition is provided solely for scientific context and compositional comparison. Such references are not intended to imply:

Equivalence to breast milk

Replication of breast milk

Superiority relative to breast milk

Substitution for breastfeeding

4. Scope of Scientific Evidence

The program may reference:

Observational research

Randomized controlled clinical trials

Mechanistic or biochemical studies

Preclinical or translational models

Regulatory safety evaluations

Study outcomes discussed reflect specific study populations, comparator formulas, endpoints, durations, and methodologies. Findings should not be generalized beyond the conditions under which the studies were conducted.

Observational findings do not establish causation.

Statements describing associations, absorption, metabolism, tolerance, visual parameters, or developmental endpoints are based on published literature and are subject to ongoing scientific evaluation.

No representation is made that ingredient inclusion results in specific clinical outcomes outside of those reported in the cited studies.

5. Regulatory Status Clarification (U.S.)

References to the U.S. Food and Drug Administration (FDA) relate solely to ingredient safety determinations and regulatory compliance under applicable law, including the Infant Formula Act (21 U.S.C. § 350a).

GRAS status pertains to safety under intended conditions of use.

FDA acknowledgment does not constitute approval of efficacy or endorsement of health benefit claims.

Infant formula products marketed in the United States must independently comply with FDA nutrient and manufacturing requirements.

Nothing in this program should be interpreted as FDA approval of clinical performance claims.

6. Advertising & Claims Context (FTC / Lanham Act)

This program is not consumer advertising and does not constitute express or implied performance claims for retail marketing.

Under U.S. law, including the Federal Trade Commission Act and the Lanham Act, health-related claims in advertising must be supported by competent and reliable scientific evidence and must not be misleading.

Nothing in this program should be used to create consumer-facing claims without independent regulatory review and substantiation assessment.

7. Ingredient-Specific Research & Sponsorship

Certain research discussed may involve proprietary ingredients supplied by commercial entities. Studies referenced may have been funded, supported, or conducted in collaboration with such entities.

Financial support or sponsorship does not imply endorsement by:

The FDA

The American Academy of Pediatrics

Any federal agency

Any medical association

Any regulatory authority

Speakers are responsible for accurately representing cited research.

8. No Representation of Long-Term Outcomes

Unless expressly stated within the cited research, no representation is made regarding long-term developmental, cognitive, metabolic, or clinical outcomes.

Emerging research areas remain under active investigation.

9. Limitation of Liability

To the maximum extent permitted by law, the organizers, sponsors, contributors, and presenters disclaim liability for any clinical decisions or interpretations derived from this program.

Healthcare professionals remain solely responsible for evaluating the appropriateness of any feeding recommendation.

10. Recording & Temporal Context

If this program is recorded or archived, viewers should consider the presentation date. Scientific evidence, regulatory standards, and clinical guidance may evolve over time.

No obligation is undertaken to update archived content.


Learn how this structural advancement in infant formula more closely mimics the unique sn-2 lipid organization found in human milk to promote softer stools and enhanced calcium absorption.